Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The burden of chronic pain.

× No keyword cloud information.

4 in total

1. Brief, self-report fibromyalgia screener evaluated in a sample of chronic pain patients.

Authors: Dawn A Marcus; Cheryl Bernstein; Kara L Albrecht
Journal: Pain Med Date: 2013-04-11 Impact factor: 3.750

Review 2. Tramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review.

Authors: Ignacio Morón Merchante; Joseph V Pergolizzi; Mart van de Laar; Hans-Ulrich Mellinghoff; Srinivas Nalamachu; Joanne O'Brien; Serge Perrot; Robert B Raffa
Journal: ISRN Family Med Date: 2013-04-11

Review 3. Reward Circuitry Plasticity in Pain Perception and Modulation.

Authors: Marcos F DosSantos; Brenda de Souza Moura; Alexandre F DaSilva
Journal: Front Pharmacol Date: 2017-11-21 Impact factor: 5.810

4. Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT_1A) Receptors Heterodimerization and Cellular Effectors (Ca²⁺, ERK1/2 and p38) Activation.

Authors: Vlad Radoi; Gerd Jakobsson; Vinko Palada; Andrej Nikosjkov; Henrik Druid; Lars Terenius; Eva Kosek; Vladana Vukojević
Journal: Molecules Date: 2022-04-06 Impact factor: 4.411

4 in total

The burden of chronic pain.

1. Brief, self-report fibromyalgia screener evaluated in a sample of chronic pain patients.

Review 2. Tramadol/Paracetamol fixed-dose combination for chronic pain management in family practice: a clinical review.

Review 3. Reward Circuitry Plasticity in Pain Perception and Modulation.

4. Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT1A) Receptors Heterodimerization and Cellular Effectors (Ca2+, ERK1/2 and p38) Activation.

4. Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT_1A) Receptors Heterodimerization and Cellular Effectors (Ca²⁺, ERK1/2 and p38) Activation.